This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Kyowa Kirin Co., Ltd., Riken Corporation, Kyowa Hakko Kirin Co., Limited. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 46 
2 out of 892 
1 out of 272 
Years Active: 2013-2025
Title: The Innovative Mind of Akifumi Kato: A Pioneer in Antibody Development
Introduction: Akifumi Kato, based in Tokyo, Japan, is an accomplished inventor with a focus on advanced biotechnological innovations. With a remarkable portfolio of four patents, he has made significant contributions to the field of antibody research. His work primarily revolves around the development of bispecific antibodies, which have vast potential in therapeutic applications.
Latest Patents: Akifumi Kato's most recent patents showcase his dedication to enhancing antibody efficacy. One notable invention is a bispecific antibody that binds to CD116 and CD131. This invention aims to offer a bispecific antibody with agonist activity to a GM-CSF receptor, consisting of two antigen-binding domains, where one binds to CD116 and the other to CD131.
Another significant patent involves an antibody with non-natural amino acids introduced within. This invention details a monoclonal antibody that includes at least one lysine derivative in its constant region, enhancing its therapeutic properties. This patent also covers the production method for the antibody and its composition, highlighting Kato's innovative approach to antibody engineering.
Career Highlights: Throughout his career, Akifumi Kato has been associated with prominent companies, including Kyowa Kirin Co., Ltd. and Riken Corporation. His experience in these research institutions has laid the foundation for his groundbreaking work in biotechnology and antibody development.
Collaborations: Collaboration is at the heart of innovation, and Kato has worked alongside esteemed colleagues such as Kensaku Sakamoto and Kazumasa Ohtake. Their collective expertise has fostered an environment of creativity and advancement in the field of therapeutics.
Conclusion: Akifumi Kato's contributions to the realm of antibody research exemplify the power of innovation in biotechnology. With multiple patents to his name and significant collaborative efforts, he continues to push the boundaries of science, paving the way for future advancements that can potentially improve human health and wellbeing. His work serves as an inspiration for aspiring inventors and researchers in the biotechnological landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile